Hester Biosciences (BOM:524669) Inventories, Work In Process: ₹211 Mil (As of Mar. 2026)


BOM:524669 Hester Biosciences Ltd BOM:524669
79 GF Score
Price ₹2,208.85
GF Value ₹1,886.51
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Hester Biosciences Inventories, Work In Process?

Hester Biosciences BOM:524669 +1.39% 79 Inventories, Work In Process is ₹211 Mil as of Mar. 2026. GuruFocus rates BOM:524669 with a GF Score™ of 79/100 and a GF Value™ of ₹1,886.51 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Hester Biosciences's work in process for the quarter that ended in Mar. 2026 was ₹211 Mil.

Hester Biosciences Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Hester Biosciences's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hester Biosciences Inventories, Work In Process Chart

Hester Biosciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 147.83 150.84 126.00 100.61 210.67

Hester Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 100.61 0.00 0.00 0.00 210.67
BOM:524669
79GF Score
Hester Biosciences Ltd BOM:524669
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hester Biosciences Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of ₹211 Mil mean?
Hester Biosciences (BOM:524669) has a Inventories, Work In Process of ₹211 Mil as of Mar. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Hester Biosciences and its competitors.
Is Hester Biosciences' Inventories, Work In Process too high?
Hester Biosciences' current Inventories, Work In Process is ₹211 Mil. Overall, Hester Biosciences has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hester Biosciences' Inventories, Work In Process compare to ZTS and UTHR?
Hester Biosciences' Inventories, Work In Process of ₹211 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Drug Manufacturers company?
A good Inventories, Work In Process depends on the Drug Manufacturers industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Hester Biosciences and its competitors. Hester Biosciences's current Inventories, Work In Process is ₹211 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hester Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Hester Biosciences (BOM:524669) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,886.51, compared to a current price of ₹2,208.85 — trading 17.1% above its estimated fair value. The current Inventories, Work In Process is ₹211 Mil. Hester Biosciences' overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Hester Biosciences (BOM:524669), the current Inventories, Work In Process is ₹211 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hester Biosciences (BOM:524669) Overvalued in 2026?

Based on GuruFocus' analysis, Hester Biosciences stock appears to be overvalued. The current stock price of ₹2,208.85 is trading 17.1% above its estimated GF Value™ of ₹1,886.51. GuruFocus considers Hester Biosciences to be Modestly Overvalued.

Key valuation signals for BOM:524669:

  • Inventories, Work In Process: ₹211 Mil
  • GF Value™: ₹1,886.51 vs. price of ₹2,208.85 (17.1% above fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the BOM:524669 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hester Biosciences Business Description

Other Exchanges HESTERBIO:India
Address Village Meda - Adraj, Taluka Kadi, District Mehsana, Mehsana, GJ, IND, 384441
Hester Biosciences Ltd is an India-based animal healthcare company. It is principally engaged in the manufacturing of veterinary vaccines and trading of veterinary health products such as goat pox vaccine, PPR vaccines, etc. The group has two principal operating and reporting segments, viz. Poultry healthcare and Animal healthcare. Maximum revenue is generated from the Poultry Healthcare segment, which offers various solutions encompassing vaccines, health products, and feed supplements, supported and packaged by its diagnostic services, R&D, quality standards, and field support, to help farmers protect flock health, enhance productivity, and drive long-term farm sustainability. Geographically, it generates maximum revenue within India, and also exports its products to other markets.
79GF Score

Get the complete analysis for BOM:524669

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,208.85
Price
₹1,886.51
GF Value